Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study

Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study

Respiratory function deficits are common sequelae for COVID-19. In this study, we aimed to identify the medical conditions that may influence lung function impairment at 12 months after SARS-CoV2 infection and to analyze the role of alpha-1 antytripsin (AAT) deficiciency (AATD). A cohort study was c...

Full description

Bibliographic Details
Main Authors: Beatriz María Jiménez-Rodríguez, Eva Maria Triviño-Ibáñez, José Gutiérrez-Fernández, Ana Dolores Romero-Ortiz, Eldis Maria Ramos-Urbina, Concepción Morales-García
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Healthcare
Subjects:
COVID-19
respiratory function tests
alpha-1 antitrypsin
long-term follow-up
Online Access:https://www.mdpi.com/2227-9032/10/12/2341

Internet

https://www.mdpi.com/2227-9032/10/12/2341

Similar Items